- Home
- ASTI vs MYNZ Comparison
ASTI vs MYNZ Comparison
Compare ASTI & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTI
- MYNZ
- Stock Information
- Founded
- ASTI 2005
- MYNZ 2021
- Country
- ASTI United States
- MYNZ Germany
- Employees
- ASTI N/A
- MYNZ N/A
- Industry
- ASTI Semiconductors
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- ASTI Technology
- MYNZ Health Care
- Exchange
- ASTI Nasdaq
- MYNZ Nasdaq
- Market Cap
- ASTI 6.7M
- MYNZ 7.9M
- IPO Year
- ASTI N/A
- MYNZ 2021
- Fundamental
- Price
- ASTI $2.13
- MYNZ $1.40
- Analyst Decision
- ASTI
- MYNZ Buy
- Analyst Count
- ASTI 0
- MYNZ 2
- Target Price
- ASTI N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- ASTI 235.3K
- MYNZ 486.3K
- Earning Date
- ASTI 11-13-2025
- MYNZ 09-26-2025
- Dividend Yield
- ASTI N/A
- MYNZ N/A
- EPS Growth
- ASTI N/A
- MYNZ N/A
- EPS
- ASTI N/A
- MYNZ N/A
- Revenue
- ASTI $41,135.00
- MYNZ $659,935.00
- Revenue This Year
- ASTI N/A
- MYNZ $26.06
- Revenue Next Year
- ASTI N/A
- MYNZ $4.97
- P/E Ratio
- ASTI N/A
- MYNZ N/A
- Revenue Growth
- ASTI N/A
- MYNZ N/A
- 52 Week Low
- ASTI $1.10
- MYNZ $1.28
- 52 Week High
- ASTI $4.41
- MYNZ $14.39
- Technical
- Relative Strength Index (RSI)
- ASTI 48.30
- MYNZ 36.29
- Support Level
- ASTI $2.08
- MYNZ $1.28
- Resistance Level
- ASTI $2.53
- MYNZ $1.73
- Average True Range (ATR)
- ASTI 0.20
- MYNZ 0.13
- MACD
- ASTI -0.00
- MYNZ -0.02
- Stochastic Oscillator
- ASTI 36.31
- MYNZ 25.52
About ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing, and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.